Premium
Chiral Discrimination of Ofloxacin Enantiomers Using DNA Double Helix Regulated by Metal Ions
Author(s) -
Fu Yan,
Duan Xiaoli,
Chen Xiongfei,
Zhang Haixiang,
Zhang Jinli,
Li Wei
Publication year - 2014
Publication title -
chirality
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 77
eISSN - 1520-636X
pISSN - 0899-0042
DOI - 10.1002/chir.22287
Subject(s) - chemistry , enantiomer , chirality (physics) , stereoselectivity , dna , desorption , helix (gastropod) , metal , metal ions in aqueous solution , ofloxacin , adsorption , enantiomeric excess , stereochemistry , enantioselective synthesis , organic chemistry , catalysis , biochemistry , ecology , antibiotics , ciprofloxacin , snail , biology , chiral symmetry breaking , physics , quantum mechanics , nambu–jona lasinio model , quark
DNA‐based chiral selectors are constructed to discriminate ofloxacin enantiomers through metal‐ion anchoring on a special DNA double helix that contains successive GC pairs. The effects of metal ions involving Mg 2+ , Ni 2+ , Cu 2+ , Ag + , and Pt 2+ were studied on the regulation of DNA chiral discrimination towards ofloxacin enantiomers. It is shown that DNA‐Cu(II) complexes exhibit the highest enantioselectivities at the [Cu 2+ ]/base ratio of 0.1. The enantiomeric excess can reach 59% in R‐enantiomer after being adsorbed by the RET‐Cu(II) complex. Stereoselective recognition of ofloxacin enantiomers on the double helix is tunable via external stimulus, providing a programmable desorption process to regenerate DNA. This DNA‐based chiral selector exhibits excellent reusability without apparent loss of enantioselectivity after three cycles of adsorption and desorption. Chirality 26:249–254, 2014 . © 2014 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom